Today: 3 July 2026
Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

Fiserv stock edges up as Clover lands CareCredit expansion — here’s what traders watch next

New York, January 14, 2026, 15:08 EST — Regular session

  • Fiserv shares edged up roughly 0.1% in afternoon trading, holding firm against the wider market downturn
  • Synchrony broadened CareCredit’s reach by integrating it further with Fiserv’s Clover platform, now covering over 40,000 providers
  • Investors are eager for the next confirmed earnings date and any news on the turnaround

Fiserv shares edged up Wednesday afternoon, hitting $66.81, even as the S&P 500 ETF slipped roughly 0.8%.

The move was modest, yet the situation remains fragile. Fiserv is working to regain trust after slashing its outlook and shaking up leadership in October, which sparked a record one-day plunge in its stock.

Broader markets dragged lower again. Wall Street’s key indexes dropped for a second day while investors digested patchy results from major banks. “It’s not unusual to see a little bit of a pullback,” said Jake Johnston, deputy CIO at Advisors Asset Management. Reuters

A company-linked headline lingered in the background. On Monday, Synchrony announced it expanded its CareCredit integration with Clover, Fiserv’s point-of-sale and commerce platform, now covering more than 40,000 health and wellness providers. The upgrade enables the entire financing process—from application to payment—directly on Clover devices. Synchrony executive Beto Casellas called it a “powerful operational advantage.” Fiserv’s Katie Whalen added the partnership should help practices “streamline payment processes and enhance the patient experience.” Synchrony

Payments stocks showed a mixed picture. PayPal gained roughly 1.6%, but Global Payments dipped 0.3%, and Fidelity National Information Services dropped close to 0.9%.

Fiserv came into Wednesday following a rough day. On Tuesday, the stock dropped 2.13% amid a broader market pullback, mirroring a selloff among other payments companies.

The downside remains clear. Financial stocks have felt the heat from policy shifts and rate news, especially concerns over a proposed cap on credit-card interest rates. That’s rattling confidence in consumer-linked payment volumes.

Investors are waiting for Fiserv to announce its next concrete milestone. The company’s investor relations page shows no scheduled events at the moment.

Fiserv’s next earnings report is tentatively set for around Feb. 4, according to some calendars, but the company hasn’t officially confirmed a date. Investors will be watching that release closely, especially for any updated guidance.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Occidental adds to proved reserves after CrownRock buy, hits 107% replacement rate in 2025
    July 3, 2026, 12:08 PM EDT. Occidental Petroleum (OXY) finished 2025 with close to 4.6 billion BOE in proved reserves, boosted by its CrownRock deal. The company reported a 107% organic reserves replacement rate for the year, showing it kept ahead of production with new finds and development, not just buying more. Occidental's reserves stretch across U.S. shale and international assets, which spreads risk and helps with capital returns. Exploration spending stayed steady, helping keep reserves up and offering flexibility. The bigger reserve pile and solid replacement rate keep Occidental in line for future earnings and free cash flow. Peers like ConocoPhillips and Chevron look to large proved reserves to keep production and cash coming in.
DAX record streak snaps as Frankfurt stocks slide; Bayer jumps 7%
Previous Story

DAX record streak snaps as Frankfurt stocks slide; Bayer jumps 7%

Kohl’s stock slides 5% as Jefferies trims target to $22, tariff ruling keeps retailers on edge
Next Story

Kohl’s stock slides 5% as Jefferies trims target to $22, tariff ruling keeps retailers on edge

Go toTop